OTS Hip
Ortoma AB • Neurology • 05/16/2025
Device Purpose
The OTS Hip device is a medical system from Ortoma AB designed to enhance hip joint replacement surgeries by providing orthopedic surgeons with tools for precise preoperative planning and real-time intraoperative guidance. It achieves this by integrating CT and X-ray medical imaging data to facilitate accurate placement of compatible prostheses during procedures like Total Hip Arthroplasty, thereby aiming to improve surgical outcomes.
Summary
The OTS Hip device, developed by Ortoma AB, is an advanced system designed to assist orthopedic surgeons throughout hip joint replacement procedures, specifically Total Hip Arthroplasty (THA). Its core functionality lies in leveraging CT and X-ray medical imaging data for precise preoperative planning, followed by real-time image-guided navigation during surgery to ensure accurate placement of compatible prostheses. This integrated approach aims to enhance surgical precision and potentially improve patient outcomes in complex hip surgeries.Following a regulatory review, the OTS Hip device was deemed substantially equivalent to other legally marketed devices for its intended use, permitting Ortoma AB to market the system. This determination, however, necessitates ongoing adherence to a comprehensive set of regulatory requirements, including general controls like annual registration and good manufacturing practices, as well as specific regulations concerning quality systems and adverse event reporting, ensuring continued safety and compliance.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What are the specific accuracy metrics achieved by the OTS Hip device for prosthesis placement compared to traditional methods?; How does the real-time image-guided navigation integrate with existing surgical workflows and what is the learning curve for surgeons?; What types of compatible prostheses are supported by the OTS Hip system, and what is the process for adding new compatible models?; Are there any long-term clinical outcomes data available or planned studies to evaluate the impact of OTS Hip use on patient recovery and revision rates?; How does the device handle potential imaging artifacts or patient movement during intraoperative guidance?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, ML-BOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly